Anti-TNF

DRUG8 trials

Sponsors

University of Rochester, University of Sao Paulo, University Hospital, Bordeaux, University of Maryland, Baltimore, Hospital Universitari Vall d'Hebron Research Institute

Conditions

Alzheimer DiseaseAnkylosing SpondylitisAtopic DermatitisCrohn's DiseaseDementiaIBDJuvenile Idiopathic ArthritisPsoriasis

Phase 3

Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes

CompletedNCT02469753

University Hospital, BordeauxAnkylosing Spondylitis

Start: 2015-10-23End: 2024-07-04Updated: 2024-07-16

The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients

WithdrawnNCT05379322

Abu Dhabi Stem Cells CenterRheumatoid Arthritis

Start: 2023-03-01End: 2023-03-01Updated: 2025-10-06

Phase 4

23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy

CompletedNCT02196480

University of Sao PauloJuvenile Idiopathic Arthritis

Start: 2008-01-31End: 2012-06-30Updated: 2014-07-22

Unknown Phase

National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study

CompletedNCT01123265

University of RochesterPsoriatic Arthritis

Start: 2010-06-30End: 2014-06-30Updated: 2015-09-21

Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease

CompletedNCT02619552

University of Maryland, BaltimoreCrohn's Disease, IBD

Start: 2011-08-31End: 2019-07-01Updated: 2022-03-09

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

Hospital Universitari Vall d'Hebron Research InstituteRheumatoid Arthritis

Start: 2016-06-30End: 2019-12-31Target: 200Updated: 2019-02-07

Molecular Signatures in Inflammatory Skin Disease

RecruitingNCT03358693

Prof. Dr. Stephan WeidingerAtopic Dermatitis, Psoriasis

Start: 2017-01-20End: 2029-12-31Target: 300Updated: 2025-07-22

A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy

CompletedNCT04571697

Janssen Research & Development, LLCAlzheimer Disease, Dementia

Start: 2020-09-28End: 2020-10-27Updated: 2025-04-27